BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2021
View Archived Issues
S1P levels found to be tied to clinical severity of COVID-19 disease
Read More
Liver metastases are immunosuppressive
Read More
ChAdOx1 nCoV-19 vaccine shows lower reactogenicity profile in older adults than in younger adults
Read More
Phase I results for talimogene laherparepvec as addition to NAC in TNBC
Read More
REGN-COV2 shows greater efficacy in COVID-19 patients with high viral load at baseline
Read More
Wistar Institute patents ACSS2 inhibitors
Read More
The Vanderbilt University synthesizes new compounds for cancer
Read More
Dana-Farber Cancer Institute presents new HDAC3 inhibitors
Read More
IHMT-TRK-284 shows efficacy in models of TRK kinase fusion or mutant-driven cancers
Read More
JS Innopharm (Shanghai) identifies RET and/or VEGFR-2 inhibitors
Read More
Platelets boost stem cell function through mitochondrial donation
Read More
New ISR pathway inhibitors presented by Praxis Biotech
Read More
Killing Mycobacterium tuberculosis, some assembly required
Read More
Imara reports phase IIa data on IMR-687 in sickle cell disease
Read More
E.U. conditional marketing authorization for Moderna's COVID-19 vaccine
Read More
Kyowa Kirin opens phase III study of bardoxolone methyl for ADPKD in Japan
Read More
Endpoints met in phase Ib/II trial of BXCL-501 for agitation in dementia
Read More
Phase III trial of sacituzumab govitecan in metastatic urothelial cancer cleared to begin in China
Read More
Windtree initiates phase II trial of lucinactant for COVID-19-associated acute lung injury
Read More
FDA lifts partial clinical hold on Marker's phase II trial of MT-401 for AML
Read More
Chemomab reports phase Ib data on CM-101 in patients with NAFLD
Read More
Treatment begins in phase I/IIa trial of AXT-107 in DME
Read More
FDA allows Cure's IND for CUREfilm Blue
Read More
Inovio reports phase II data on VGX-3100 to treat HPV-16- and -18-associated vulvar dysplasia
Read More
Phase III ultraVIOLET study of oteseconazole for recurrent VVC meets endpoints
Read More
Cerecor reports phase II proof-of-concept data for CERC-002 in COVID-19 ARDS
Read More